Armata Pharma earnings missed by $0.06, revenue topped estimates

Investing.com - Armata Pharma (NYSE: ARMP) reported second quarter EPS of $-0.450, $0.06 worse than the analyst estimate of $-0.390. Revenue for the quarter came in at $2.17M versus the consensus estimate of $1.38M.

Armata Pharma’s stock price closed at $2.46. It is up 82.220% in the last 3 months and down -9.230% in the last 12 months.

Armata Pharma saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Armata Pharma’s stock price’s past reactions to earnings here.

According to InvestingPro, Armata Pharma’s Financial Health score is "fair performance".

Check out Armata Pharma’s recent earnings performance, and Armata Pharma’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar